Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-13

Clinical Trial Update: Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control Trial [Phase 3]

View source ↗

Summary

This document describes a Phase 3 pilot randomized, double-blind trial evaluating whether olanzapine reduces opioid craving and misuse in cancer patients receiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Misuse, Opioid | Phase 3 | Status: RECRUITING